NCT07133815View on ClinicalTrials.gov

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG

SHR-1918

SHR-1918

Trial Locations (1)

410007

Xiangya Second Hospital of Central South University, Changsha

All Listed Sponsors

lead

Beijing Suncadia Pharmaceuticals Co., Ltd

INDUSTRY